新闻动态
News
-
Lingyi Biotech Featured in Business Insider, ACESSNewswire & Other Major Financial Outlets
2025-07-29
-
Lingyi Biotech Showcases Groundbreaking Clinical Advancements in Next-Generation Regulatable Gene Therapies at ASGCT 2025
2025-05-23
-
Lingyi Biotech's LY-M001 Injection Honored as "Rare Disease Drug of the Year" at 2024 China Biopharma Innovation Rankings
2025-01-03
-
Lingyi Bio Honored as One of the 'Top 10 Innovative Companies in Precision Medicine for 2024'
2025-01-03
-
Strong Alliance for a Win-Win Future | Lingyi Biotech and Jolly Pharmaceutical Sign Strategic Cooperation Framework Agreement
2025-01-03
-
Lingyi Biotech's Gene Therapy Drug LY-M001 Injection Granted FDA Rare Pediatric Disease Designation (RPDD)
2025-01-03
-
Clinical Trial Breakthrough: Shanghai Children's Medical Center Completes World's First Gene Therapy for Adolescent with Gaucher Disease I
2025-01-03
-
Lingyi Biotech's LY-M003 Injection Completes First Gene Therapy Dosing in Wilson's Disease Patient
2025-01-03
